Delphia (USA) Inc. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2022$118,000
-17.5%
31,709
+24.3%
0.08%
-24.3%
Q1 2022$143,00025,5040.11%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders